Pyrilamine (Maleate) Overview Categories 21 Ophthalmological preparations21.6 Non-specific anticonjunctivitis preparations 25 Drugs acting on the respiratory tract25.2 Antitussives25.2.1 Cold preparations Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Pyrilamine (Maleate) Manufacturers of Pyrilamine (Maleate) Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Pyrilamine (Maleate)'s dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 0.1 %0.1 (0.1)4 hourlyOphthalmicAs required.25 to 50 mg38 (37.5)4 hourlyPO Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Pyrilamine (Maleate) is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Pyrilamine (Maleate) is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Pyrilamine (Maleate) Back to top Manufacturers of Pyrilamine (Maleate) in Pakistan Barrett Jaens Pfizer Remington Back to top Previous Drug Generic - Next Drug Generic